title: Caveolin-1, caveolae, and glioblastoma.
abstract: Glioblastoma multiforme (GBM) is the most common malignant brain tumor and is characterized by high invasiveness, poor prognosis, and limited therapeutic options. Biochemical and morphological experiments have shown the presence of caveolae in glioblastoma cells. Caveolae are flask-shaped plasma membrane subdomains that play trafficking, mechanosensing, and signaling roles. Caveolin-1 is a membrane protein that participates in the formation of caveolae and binds a multitude of signaling proteins, compartmentalizing them in caveolae and often directly regulating their activity via binding to its scaffolding domain. Caveolin-1 has been proposed to behave either as a tumor suppressor or as an ongogene depending on the tumor type and progress. This review discusses the existing information on the expression and function of caveolin-1 and caveolae in GBM and the role of this organelle and its defining protein on cellular signaling, growth, and invasiveness of GBM. We further analyze the available data suggesting caveolin-1 could be a target in GBM therapy.
authors.affiliation: University of Queensland School of Pharmacy, PACE, 20 Cornwall St., Woollloongabba QLD 4102, Australia. m.parat@uq.edu.au
authors.forename: Marie-Odile
authors.initials: MO
authors.lastname: Parat
authors.forename: Gregory J
authors.initials: GJ
authors.lastname: Riggins
mesh_terms: D000818:Animals; D021941:Caveolae / Q000502:physiology*; D051242:Caveolin 1 / Q000378:metabolism*; D005909:Glioblastoma / Q000378:metabolism* / Q000473:pathology*; D006801:Humans; D021962:Membrane Microdomains
chemical_list: D051242:Caveolin 1